Aspirin use and risk of cataract in posttrial follow-up of physicians' health study I

Archives of Ophthalmology

Volumn 119, Issue 3, 2001, Pages 405-412

  Christen, William G ^a   Ajani, Umed A ^a   Schaumberg, Debra A ^a   Glynn, Robert J ^a,b   Manson, JoAnn E ^a,b   Hennekens, Charles H ^c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID;

ARTICLE; CATARACT; CATARACT EXTRACTION; DRUG EFFECT; DRUG USE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 0035090258     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.119.3.405     Document Type: Article

References (31)

1. Aspirin and senile cataracts in rheumatoid arthritis
2. Distribution of salicylate in lens and intraocular fluids and its effect on cataract formation
3. Do aspirin-like analgesics protect against cataract?
4. Aspirin and cataracts
5. Lack of evidence for aspirin use and prevention of cataracts
6. Is aspirin use associated with lower rates of cataracts in diabetic individuals?
7. Cataract and health status: A case-control study
8. India-US case-control study of age-related cataracts
9. Does aspirin affect the rate of cataract formation? cross-sectional results during a randomized double-blind placebo controlled trial to prevent serious vascular events
10. Risk factors for age-related cortical, nuclear, and posterior subcapsular cataracts
11. The lens opacities case-control study: Risk factors for cataract
12. Aspirin use and chronic diseases: A cohort study of the elderly
13. A prospective study of aspirin use and cataract extraction in women
14. Medications and cataract: The Blue Mountains Eye Study
15. Randomized trial of prophylactic daily aspirin in British male doctors
16. Aspirin effects on the development of cataract in patients with diabetes mellitus: Early treatment diabetic retinopathy study report 16
17. Low-dose aspirin and risks of cataract in a randomized trial of US physicians
18. Low-dose aspirin and risks of cataract and subtypes in a randomized trial of US physicians
19. Data Monitoring Board of the Physicians' Health Study. Issues in the early termination of the aspirin component of the Physicians' Health Study
20. Final report on the aspirin component of the ongoing Physicians' Health Study
21. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease
22. Regression models and life-tables
23. Acetylation of lens crystallins: A possible mechanism by which aspirin could prevent cataract formation
24. Reaction of aspirin with cysteinyl residues of lens γ-crystallins: A mechanism for the proposed anti-cataract effect of aspirin
25. Effect of aspirin and sodium salicylate on cataract development in diabetic rats
26. Aspirin stimulates insulin and glucagon secretion and increases glucose tolerance in normal and diabetic subjects
27. The effect of acetylsalicylic acid on insulin response to glucose and arginine in normal man
28. Drugs, including alcohol, that act as risk factors for cataract, and possible protection against cataract by aspirin-like analgesics and cyclopenthiazide
29. Antioxidant characteristics of some potential anticataract agents: Studies of aspirin, paracetamol, and bendazac provide support for an oxidative component of cataract